Fig. 14From: Computational modeling, ligand-based drug design, drug-likeness and ADMET properties studies of series of chromen-2-ones analogues as anti-cancer agents3D and 2D binding modes of designed compound 12 with the active pocket of the ER+ receptorBack to article page